US Stock MarketDetailed Quotes

MNMD Mind Medicine

Watchlist
  • 7.3100
  • +0.1600+2.24%
Close Dec 11 16:00 ET
  • 7.4100
  • +0.1000+1.37%
Post 19:55 ET
536.05MMarket Cap-4.27P/E (TTM)

Mind Medicine Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
14.69%24.79M
-16.19%24.46M
6.43%22.2M
41.51%93.87M
59.75%22.21M
27.28%21.62M
72.25%29.18M
12.74%20.86M
-29.33%66.33M
-20.83%13.9M
Selling and administrative expenses
-9.62%7.6M
-31.89%9.81M
27.06%10.5M
38.39%41.74M
110.24%10.66M
-8.66%8.41M
89.14%14.41M
-0.01%8.26M
-48.93%30.16M
-24.04%5.07M
-General and administrative expense
-9.62%7.6M
-31.89%9.81M
27.06%10.5M
38.39%41.74M
110.24%10.66M
-8.66%8.41M
89.14%14.41M
-0.01%8.26M
-48.93%30.16M
-24.04%5.07M
Research and development costs
30.18%17.19M
-0.89%14.65M
-7.10%11.71M
44.11%52.12M
30.76%11.55M
69.88%13.2M
58.45%14.78M
23.03%12.6M
3.97%36.17M
-18.86%8.83M
Operating profit
-14.69%-24.79M
16.19%-24.46M
-6.43%-22.2M
-41.51%-93.87M
-59.75%-22.21M
-27.28%-21.62M
-72.25%-29.18M
-12.74%-20.86M
29.33%-66.33M
20.83%-13.9M
Net non-operating interest income expense
139.04%2.78M
102.14%2.65M
-4.83%1.22M
211.97%4.66M
-13.97%905K
223.06%1.16M
1,498.78%1.31M
4,855.56%1.28M
516.43%1.5M
856.83%1.05M
Non-operating interest income
135.21%3.51M
124.50%3.12M
21.76%1.66M
----
----
314.17%1.49M
--1.39M
--1.36M
----
----
Non-operating interest expense
121.65%727K
505.19%466K
471.05%434K
----
----
--328K
--77K
--76K
----
----
Total other finance cost
----
----
----
-211.97%-4.66M
----
----
----
----
-516.43%-1.5M
----
Other net income (expense)
229.17%8.33M
1,369.21%15.95M
-538.11%-33.42M
-181.22%-6.53M
-132.27%-2.56M
1,733.33%2.53M
-1,209.38%-1.26M
-6,565.43%-5.24M
40,100.00%8.04M
2,849.13%7.95M
Gain on sale of security
222.67%8.33M
1,167.06%13.41M
-538.11%-33.42M
-180.60%-6.48M
-132.28%-2.56M
1,770.29%2.58M
-1,312.36%-1.26M
-11,737.78%-5.24M
9,446.51%8.04M
4,513.33%7.94M
Special income (charges)
--0
--2.54M
----
----
----
--0
--0
----
----
----
-Less:Other special charges
----
---2.54M
----
----
----
----
----
----
----
----
Other non- operating income (expenses)
----
----
----
-2,650.00%-51K
--0
---51K
----
----
-98.11%2K
100.92%1K
Income before tax
23.65%-13.68M
79.90%-5.85M
-119.22%-54.4M
-68.55%-95.73M
-386.72%-23.86M
-8.72%-17.92M
-71.79%-29.13M
-34.49%-24.82M
39.70%-56.8M
72.74%-4.9M
Income tax
Net income
23.65%-13.68M
79.90%-5.85M
-119.22%-54.4M
-68.55%-95.73M
-386.72%-23.86M
-8.72%-17.92M
-71.79%-29.13M
-34.49%-24.82M
38.95%-56.8M
70.87%-4.9M
Net income continuous Operations
23.65%-13.68M
79.90%-5.85M
-119.22%-54.4M
-68.55%-95.73M
-386.72%-23.86M
-8.72%-17.92M
-71.79%-29.13M
-34.49%-24.82M
38.95%-56.8M
70.87%-4.9M
Minority interest income
Net income attributable to the parent company
23.65%-13.68M
79.90%-5.85M
-119.22%-54.4M
-68.55%-95.73M
-386.72%-23.86M
-8.72%-17.92M
-71.79%-29.13M
-34.49%-24.82M
38.95%-56.8M
70.87%-4.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
23.65%-13.68M
79.90%-5.85M
-119.22%-54.4M
-68.55%-95.73M
-386.72%-23.86M
-8.72%-17.92M
-71.79%-29.13M
-34.49%-24.82M
38.95%-56.8M
70.87%-4.9M
Basic earnings per share
60.00%-0.18
89.47%-0.08
-75.38%-1.14
-32.61%-2.44
-2,850.00%-0.59
19.64%-0.45
-26.67%-0.76
1.52%-0.65
45.88%-1.84
96.61%-0.02
Diluted earnings per share
40.00%-0.27
65.79%-0.26
-75.38%-1.14
-32.61%-2.44
-2,850.00%-0.59
19.64%-0.45
-26.67%-0.76
1.52%-0.65
45.88%-1.84
96.61%-0.02
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
--
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 14.69%24.79M-16.19%24.46M6.43%22.2M41.51%93.87M59.75%22.21M27.28%21.62M72.25%29.18M12.74%20.86M-29.33%66.33M-20.83%13.9M
Selling and administrative expenses -9.62%7.6M-31.89%9.81M27.06%10.5M38.39%41.74M110.24%10.66M-8.66%8.41M89.14%14.41M-0.01%8.26M-48.93%30.16M-24.04%5.07M
-General and administrative expense -9.62%7.6M-31.89%9.81M27.06%10.5M38.39%41.74M110.24%10.66M-8.66%8.41M89.14%14.41M-0.01%8.26M-48.93%30.16M-24.04%5.07M
Research and development costs 30.18%17.19M-0.89%14.65M-7.10%11.71M44.11%52.12M30.76%11.55M69.88%13.2M58.45%14.78M23.03%12.6M3.97%36.17M-18.86%8.83M
Operating profit -14.69%-24.79M16.19%-24.46M-6.43%-22.2M-41.51%-93.87M-59.75%-22.21M-27.28%-21.62M-72.25%-29.18M-12.74%-20.86M29.33%-66.33M20.83%-13.9M
Net non-operating interest income expense 139.04%2.78M102.14%2.65M-4.83%1.22M211.97%4.66M-13.97%905K223.06%1.16M1,498.78%1.31M4,855.56%1.28M516.43%1.5M856.83%1.05M
Non-operating interest income 135.21%3.51M124.50%3.12M21.76%1.66M--------314.17%1.49M--1.39M--1.36M--------
Non-operating interest expense 121.65%727K505.19%466K471.05%434K----------328K--77K--76K--------
Total other finance cost -------------211.97%-4.66M-----------------516.43%-1.5M----
Other net income (expense) 229.17%8.33M1,369.21%15.95M-538.11%-33.42M-181.22%-6.53M-132.27%-2.56M1,733.33%2.53M-1,209.38%-1.26M-6,565.43%-5.24M40,100.00%8.04M2,849.13%7.95M
Gain on sale of security 222.67%8.33M1,167.06%13.41M-538.11%-33.42M-180.60%-6.48M-132.28%-2.56M1,770.29%2.58M-1,312.36%-1.26M-11,737.78%-5.24M9,446.51%8.04M4,513.33%7.94M
Special income (charges) --0--2.54M--------------0--0------------
-Less:Other special charges -------2.54M--------------------------------
Other non- operating income (expenses) -------------2,650.00%-51K--0---51K---------98.11%2K100.92%1K
Income before tax 23.65%-13.68M79.90%-5.85M-119.22%-54.4M-68.55%-95.73M-386.72%-23.86M-8.72%-17.92M-71.79%-29.13M-34.49%-24.82M39.70%-56.8M72.74%-4.9M
Income tax
Net income 23.65%-13.68M79.90%-5.85M-119.22%-54.4M-68.55%-95.73M-386.72%-23.86M-8.72%-17.92M-71.79%-29.13M-34.49%-24.82M38.95%-56.8M70.87%-4.9M
Net income continuous Operations 23.65%-13.68M79.90%-5.85M-119.22%-54.4M-68.55%-95.73M-386.72%-23.86M-8.72%-17.92M-71.79%-29.13M-34.49%-24.82M38.95%-56.8M70.87%-4.9M
Minority interest income
Net income attributable to the parent company 23.65%-13.68M79.90%-5.85M-119.22%-54.4M-68.55%-95.73M-386.72%-23.86M-8.72%-17.92M-71.79%-29.13M-34.49%-24.82M38.95%-56.8M70.87%-4.9M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 23.65%-13.68M79.90%-5.85M-119.22%-54.4M-68.55%-95.73M-386.72%-23.86M-8.72%-17.92M-71.79%-29.13M-34.49%-24.82M38.95%-56.8M70.87%-4.9M
Basic earnings per share 60.00%-0.1889.47%-0.08-75.38%-1.14-32.61%-2.44-2,850.00%-0.5919.64%-0.45-26.67%-0.761.52%-0.6545.88%-1.8496.61%-0.02
Diluted earnings per share 40.00%-0.2765.79%-0.26-75.38%-1.14-32.61%-2.44-2,850.00%-0.5919.64%-0.45-26.67%-0.761.52%-0.6545.88%-1.8496.61%-0.02
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----------------Unqualified Opinion--
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.